載入...
GlycA: A New Biomarker for Systemic Inflammation and Cardiovascular Disease (CVD) Risk Assessment
The GlycA test is a recently developed proton nuclear magnetic resonance ((1)H-NMR) spectroscopy-based assay that has been gaining increased interest as a serum biomarker for systemic inflammation, and consequently, as a potential biomarker for cardiovascular disease (CVD) risk assessment. The test...
Na minha lista:
| 發表在: | J Lab Precis Med |
|---|---|
| Main Authors: | , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
2020
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7194207/ https://ncbi.nlm.nih.gov/pubmed/32363327 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/jlpm.2020.03.03 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|